Acute Hepatitis in Pediatrics

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Dec 30, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding acute hepatitis in children, a condition that can be tricky to identify. The researchers want to learn about the different symptoms that children with acute hepatitis might experience and how these symptoms show up in blood tests. By collecting and analyzing this information, they hope to gain a clearer picture of the disease and any complications that might arise from it.

If your child is between 0 and 17 years old and has been diagnosed with acute hepatitis, they may be eligible to participate in the study. Participation involves being monitored and having their health information collected without any changes to their regular medical care. The study is currently recruiting participants, so it's a great opportunity for families who want to contribute to a better understanding of this condition in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 0 and 17 years (extremes included).
• • Access to PSP and/or hospitalized (OBI or hospitalization)
• • Diagnosis of acute hepatitis
• Exclusion Criteria:
• • Refusal of the parent/guardian to participate in the study.
• • Mild hypertransaminasemia (\<5 times the upper limit of normal) in a patient with known chronic liver dysfunction (e.g. liver cirrhosis).
• • Neonatal jaundice without hepatocyte involvement or signs of cholestasis (prevalence of indirect bilirubin with normal AST, ALT and GGT).